Literature DB >> 35050131

Modelling Metabolic Shifts during Cardiomyocyte Differentiation, Iron Deficiency and Transferrin Rescue Using Human Pluripotent Stem Cells.

Benjamin B Johnson1, Johannes Reinhold1, Terri L Holmes1, Jamie A Moore1, Verity Cowell1, Andreia S Bernardo2,3, Stuart A Rushworth1, Vassilios Vassiliou1, James G W Smith1.   

Abstract

Cardiomyocytes rely on specialised metabolism to meet the high energy demand of the heart. During heart development, metabolism matures and shifts from the predominant utilisation of glycolysis and glutamine oxidation towards lactate and fatty acid oxidation. Iron deficiency (ID) leads to cellular metabolism perturbations. However, the exact alterations in substrate metabolism during ID are poorly defined. Using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM), the present study investigated changes in major metabolic substrate utilisation in the context of ID or upon transferrin rescue. Typically, during hiPSC-CM differentiation, the greatest increase in total metabolic output and rate was seen in fatty acid metabolism. When ID was induced, hiPSC-CMs displayed increased reliance on glycolytic metabolism, and six TCA cycle, five amino acid, and four fatty acid substrates were significantly impaired. Transferrin rescue was able to improve TCA cycle substrate metabolism, but the amino acid and fatty acid metabolism remained perturbed. Replenishing iron stores partially reverses the adverse metabolic changes that occur during ID. Understanding the changes in metabolic substrate utilisation and their modification may provide potential for discovery of new biomarkers and therapeutic targets in cardiovascular diseases.

Entities:  

Keywords:  cardiomyocytes; iron deficiency; pluripotent stem cells

Year:  2021        PMID: 35050131      PMCID: PMC8778576          DOI: 10.3390/metabo12010009

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  58 in total

Review 1.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

2.  Translational regulation of mammalian and Drosophila citric acid cycle enzymes via iron-responsive elements.

Authors:  N K Gray; K Pantopoulos; T Dandekar; B A Ackrell; M W Hentze
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

3.  Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.

Authors:  David L M van der Meer; Tatjana Degenhardt; Sami Väisänen; Philip J de Groot; Merja Heinäniemi; Sacco C de Vries; Michael Müller; Carsten Carlberg; Sander Kersten
Journal:  Nucleic Acids Res       Date:  2010-01-27       Impact factor: 16.971

Review 4.  Iron biology in immune function, muscle metabolism and neuronal functioning.

Authors:  J L Beard
Journal:  J Nutr       Date:  2001-02       Impact factor: 4.798

5.  Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.

Authors:  Cláudia Correia; Alexey Koshkin; Patrícia Duarte; Dongjian Hu; Ana Teixeira; Ibrahim Domian; Margarida Serra; Paula M Alves
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

6.  Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy.

Authors:  Edward T Chouchani; Carmen Methner; Guido Buonincontri; Chou-Hui Hu; Angela Logan; Stephen J Sawiak; Michael P Murphy; Thomas Krieg
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

7.  Chemically defined generation of human cardiomyocytes.

Authors:  Paul W Burridge; Elena Matsa; Praveen Shukla; Ziliang C Lin; Jared M Churko; Antje D Ebert; Feng Lan; Sebastian Diecke; Bruno Huber; Nicholas M Mordwinkin; Jordan R Plews; Oscar J Abilez; Bianxiao Cui; Joseph D Gold; Joseph C Wu
Journal:  Nat Methods       Date:  2014-06-15       Impact factor: 28.547

8.  Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function.

Authors:  Martijn F Hoes; Niels Grote Beverborg; J David Kijlstra; Jeroen Kuipers; Dorine W Swinkels; Ben N G Giepmans; Richard J Rodenburg; Dirk J van Veldhuisen; Rudolf A de Boer; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2018-02-27       Impact factor: 15.534

9.  CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.

Authors:  Diogo Mosqueira; Ingra Mannhardt; Jamie R Bhagwan; Katarzyna Lis-Slimak; Puspita Katili; Elizabeth Scott; Mustafa Hassan; Maksymilian Prondzynski; Stephen C Harmer; Andrew Tinker; James G W Smith; Lucie Carrier; Philip M Williams; Daniel Gaffney; Thomas Eschenhagen; Arne Hansen; Chris Denning
Journal:  Eur Heart J       Date:  2018-11-14       Impact factor: 29.983

10.  Short exposure to hyperoxia causes cultured lung epithelial cell mitochondrial dysregulation and alveolar simplification in mice.

Authors:  David Garcia; Jennifer F Carr; Felix Chan; Abigail L Peterson; Kimberlyn A Ellis; Alejandro Scaffa; Andrew J Ghio; Hongwei Yao; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2020-11-03       Impact factor: 3.756

View more
  1 in total

1.  Biofortification of Three Cultivated Mushroom Species with Three Iron Salts-Potential for a New Iron-Rich Superfood.

Authors:  Sylwia Budzyńska; Marek Siwulski; Monika Gąsecka; Zuzanna Magdziak; Pavel Kalač; Przemysław Niedzielski; Mirosław Mleczek
Journal:  Molecules       Date:  2022-04-04       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.